Bristol Myers pledges to spend $300M on addressing racial, health disparities
Bio Pharma Dive
AUGUST 12, 2020
The drugmaker aims to double Black and Latinx representation in its executive ranks, among other commitments.
Sat.Aug 08, 2020 - Fri.Aug 14, 2020
340 
How pharma digital marketing can excel
World of DTC Marketing
AUGUST 9, 2020
Pharma digital marketing has been lagging behind key trends for a long while. Let’s face it, pharma organizations are not made for speed while digital marketing is all about “now” Digital marketing is also about experimentation and learning from successes as well as failures. An internal team of consultants, dedicated to digital, can add a lot of value to a company.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA accepts application for self-administered Xolair use
Pharma Times
AUGUST 13, 2020
If approved drug would offer a more flexible option for patients
American Gene Technologies Gets Go-Ahead to Test Possible HIV Cure
BioSpace
AUGUST 12, 2020
American Gene Technologies (AGT), based in Rockville, Maryland, received the go-ahead from the U.S. Food and Drug Administration (FDA) to begin a Phase I clinical trial of AGT103-T, a gene therapy, to eliminate HIV from infected individuals.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
FDA gives speedy approval to another Duchenne drug
Bio Pharma Dive
AUGUST 12, 2020
Viltepso, from Japanese drugmaker NS Pharma, is approved to treat the same subset of Duchenne patients as Sarepta's Vyondys 53.
Pharma is hiring
World of DTC Marketing
AUGUST 13, 2020
IN BRIEF: Pharma companies have been posting jobs on LinkedIn almost every day. While most offices remain closed pharma is preparing for the launch of new products and has to have the infrastructure to ensure a successful launch. I keep in touch with all my clients via email newsletters and ask them to “stay in touch” It seems that this year, I’ve been seeing more people leave for other jobs within the industry or clients asking me to suggest people for open positions.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Potential HIV cure Phase I trial gets FDA green light
Outsourcing Pharma
AUGUST 11, 2020
American Gene Technologies has received the agencyâs approval to launch the first human trial for its lead HIV program, starting in Baltimore and DC.
Seres finds the microbiome data it's been waiting for
Bio Pharma Dive
AUGUST 10, 2020
The biotech's value more than quadrupled after reporting pivotal data that, according to executives, "substantially exceeded" what's needed for approval.
In the News: July Regulatory and Development Updates
Camargo
AUGUST 13, 2020
Each month, Camargo’s “In the News” series will highlight important changes and advancements in the. The post In the News: July Regulatory and Development Updates appeared first on Camargo.
Pfizer inks manufacturing deal with Gilead for COVID-19 med remdesivir
Pharma Times
AUGUST 10, 2020
Pfizer becomes one of multiple external manufacturing organisations supporting scale-up of treatment
Sophia Genetics launches AI tool to find COVID-19 ‘unknowns’
pharmaphorum
AUGUST 10, 2020
Swiss medical data specialist Sophia Genetics has launched a platform that will sift through data generated at more than 1,000 hospitals around the world to try to work out how the COVID-19 pandemic will evolve in the coming months and years. The data mining tool will be used to try to unearth some of the many unknowns with the virus, using next-generation sequencing (NGS) to see how the genome of SARS-CoV-2 changes over time, along with patient genetic information, results of lung and CT scans,
US puts Kodak loan on hold after stock scrutiny
Bio Pharma Dive
AUGUST 10, 2020
Lawmakers questioned the timing of stock options granted to Kodak executives a day before the planned $765 million loan was announced. An SEC investigation is reportedly underway.
Using Machine Learning to ID Potential COVID-19 Treatments
BioSpace
AUGUST 12, 2020
Researchers at the University of California, Riverside leveraged machine learning to screen more than 10 million commercially available small molecules for interactions with SARS-CoV-2 viral proteins, and found hundreds of drugs that might offer treatments against COVID-19.
AstraZeneca ships first doses of flu vaccine
Pharma Times
AUGUST 14, 2020
Company will manufacture over 25% more doses than previously planned
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Species-specific Demands Trigger New R&D Areas in Animal Healthcare Market, Notices a New FMI Study
Pharma Mirror
AUGUST 14, 2020
Animal feed represents the most profitable product type segment, presenting multiple investment opportunities for animal healthcare market operators. Top selling potential of animal feed additives is attributed to a growing focus on disease outbreak prevention rather than on curing disease afflicted animals. Animal healthcare market in China and Japan is especially observing robust demand growth.
Argentina, Mexico line up to produce AstraZeneca, Oxford coronavirus vaccine
Bio Pharma Dive
AUGUST 13, 2020
The manufacturing deal could help supply Latin America with Oxford's shot, which is one of the most advanced in clinical testing.
Moderna Signs COVID-19 Vaccine Supply Deal with U.S. for $1.525 Billion
BioSpace
AUGUST 11, 2020
Moderna signed a contract worth up to $1.525 billion with the U.S. government to supply 100 million doses of mRNA-1273, the company’s experimental COVID-19 vaccine.
Finding resilience after an HIV diagnosis
pharmaphorum
AUGUST 12, 2020
Author and journalist John-Manuel Andriote has spent much of his career writing about the impact of HIV/AIDS – a job that became much more personal when he himself was diagnosed in 2005. He tells pharmaphorum about the importance of resilience in coping with a serious illness. John first began writing about HIV/AIDS as a journalist in 1986. “I had two friends of mine in their 20s die from AIDS while I was in journalism school in 1985 – a time when AIDS was always in the news and there was a lot
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
QBiotics Announces Clinical Collaboration with MSD Targeting Unresectable Melanoma
Pharma Mirror
AUGUST 14, 2020
QBiotics Group Limited (QGL), a life sciences company developing novel anticancer and wound healing pharmaceuticals, is pleased to announce that it has entered into an agreement with MSD (tradename of Merck & Co., Inc., Kenilworth, NJ, USA), to evaluate use of its lead molecule tigilanol tiglate, in combination with Keytruda(R) (pembrolizumab) in patients with unresectable.
Moderna gets $1.5B from US for coronavirus vaccine supply
Bio Pharma Dive
AUGUST 11, 2020
The U.S. has already invested heavily in Moderna's vaccine, having previously committed $1 billion to fund clinical trials and manufacturing scale-up.
Sinopharm Publishes Positive Data from Phase I/II COVID-19 Vaccine Study
BioSpace
AUGUST 13, 2020
A COVID-19 vaccine candidate developed by Chinese pharmaceutical company Sinopharm triggered antibody-based immune responses in early and mid-stage trials.
Roche post mixed results for etrolizumab in ulcerative colitis
Pharma Times
AUGUST 10, 2020
Phase III study of drug in Crohn's disease is ongoing
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Evidence of positive impact of pharmacists on patient safety published by FIP
Pharma Mirror
AUGUST 14, 2020
The positive impacts of pharmacists in supporting medication without harm are described in a new publication from the International Pharmaceutical Federation (FIP) released today. The World Health Organization reports that one in four patients is harmed by the care they receive in primary and ambulatory care settings, including harm from medicines. It estimates the global.
Russia, with scant study data, approves coronavirus vaccine
Bio Pharma Dive
AUGUST 11, 2020
The shot, developed by the state-backed Gamaleya Research Institute, hasn't yet been tested in the large, placebo-controlled tests scientists emphasize are needed to prove a vaccine is protective.
Companies Press Ahead with COVID-19 Antibody Therapies
BioSpace
AUGUST 11, 2020
Although the world is eagerly awaiting news of an effective and safe vaccine against COVID-19, several companies are moving ahead testing therapeutic antibodies against the disease.
Celleron picks up discarded cancer drug from Roche
Pharma Times
AUGUST 13, 2020
UK biopharma company signs licensing agreement for emactuzumab
What Exactly Is Tadalafil?
Pharma Mirror
AUGUST 13, 2020
Tadalafil is a prescription drug well-known to men over the age of 40 who usually have to deal with episodic or permanent erectile dysfunction. Yet there’s more to this substance than its typical use in managing impotence by improving the blood flow to the genitals. The substance is used in many other treatments and has. The post What Exactly Is Tadalafil?
Bayer, contrasting pharma peers, builds up women's health business with $425M deal
Bio Pharma Dive
AUGUST 11, 2020
Acquiring KaNDy Therapeutics hands Bayer an experimental menopause drug that, according to the company, could become a blockbuster product.
Bad behaviour: why understanding human behaviour can improve outcomes
pharmaphorum
AUGUST 10, 2020
Why did I do that? A common question I often ask myself after opening the biscuit packet for the third time in an hour. Only ten minutes before I had a mental argument with myself, which I thought I had won, promising not to eat another one until tomorrow. The process that goes on inside our heads, affecting the good and bad choices we make regarding our health every day, is the focus of health psychology and the growing interest around behavioural change.
BMS’ Opdivo improves survival in gastric and oesophageal cancers
Pharma Times
AUGUST 12, 2020
Topline results published from CheckMate-649 and CheckMate-577 studies
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Let's personalize your content